Moore JP - Search Results

1

Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health.

Racine-Brzostek SE, Yang HS, Jack GA, Chen Z, Chadburn A, Ketas TJ, Francomano E, Klasse PJ, Moore JP, McDonough KA, Girardin RC, Dupuis AP, Payne AF, Ma LX, Sweeney J, Zhong E, Yee J, Cushing MM, Zhao Z. Racine-Brzostek SE, et al. Among authors: moore jp. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2025-e2034. doi: 10.1210/clinem/dgab004. J Clin Endocrinol Metab. 2021. PMID: 33524125 Free PMC article.

2

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

3

Kinetics of the HIV-CD4 interactions and virus-cell fusion.

Klasse PJ, Moore JP. Klasse PJ, et al. Among authors: moore jp. AIDS. 1992 Mar;6(3):325-7. doi: 10.1097/00002030-199203000-00011. AIDS. 1992. PMID: 1567578 No abstract available.

4

Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.

Moore JP, Klasse PJ. Moore JP, et al. AIDS Res Hum Retroviruses. 1992 Apr;8(4):443-50. doi: 10.1089/aid.1992.8.443. AIDS Res Hum Retroviruses. 1992. PMID: 1599754

5

Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Klasse PJ, Moore JP. Klasse PJ, et al. Among authors: moore jp. J Virol. 1996 Jun;70(6):3668-77. doi: 10.1128/JVI.70.6.3668-3677.1996. J Virol. 1996. PMID: 8648701 Free PMC article.

6

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP. Binley JM, et al. Among authors: moore jp. J Virol. 1997 Apr;71(4):2799-809. doi: 10.1128/JVI.71.4.2799-2809.1997. J Virol. 1997. PMID: 9060635 Free PMC article.

7

A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.

Trkola A, Matthews J, Gordon C, Ketas T, Moore JP. Trkola A, et al. Among authors: moore jp. J Virol. 1999 Nov;73(11):8966-74. doi: 10.1128/JVI.73.11.8966-8974.1999. J Virol. 1999. PMID: 10516002 Free PMC article.

8

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.

Binley JM, Trkola A, Ketas T, Schiller D, Clas B, Little S, Richman D, Hurley A, Markowitz M, Moore JP. Binley JM, et al. Among authors: moore jp. J Infect Dis. 2000 Sep;182(3):945-9. doi: 10.1086/315774. Epub 2000 Aug 1. J Infect Dis. 2000. PMID: 10950795

9

Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells.

Ketas TJ, Frank I, Klasse PJ, Sullivan BM, Gardner JP, Spenlehauer C, Nesin M, Olson WC, Moore JP, Pope M. Ketas TJ, et al. Among authors: moore jp. J Virol. 2003 Feb;77(4):2762-7. doi: 10.1128/jvi.77.4.2762-2767.2003. J Virol. 2003. PMID: 12552019 Free PMC article.

10

Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types.

Ketas TJ, Klasse PJ, Spenlehauer C, Nesin M, Frank I, Pope M, Strizki JM, Reyes GR, Baroudy BM, Moore JP. Ketas TJ, et al. Among authors: moore jp. AIDS Res Hum Retroviruses. 2003 Mar;19(3):177-86. doi: 10.1089/088922203763315678. AIDS Res Hum Retroviruses. 2003. PMID: 12689409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

751 results

Search Page